The prognostic value of the pretreatment lung immune prognostic index in patients with metastatic hormone-sensitive and castration-resistant prostate cancer

BACKGROUND: The lung immune prognostic index (LIPI) was first reported to predict the effectiveness of immune checkpoint inhibitors in patients with metastatic non-small cell lung cancer and there are no studies investigating the predictive value of LIPI for patients with PCa. This study explores th...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhipeng, Liu, Haoyang, Zhao, Jinge, Chen, Junru, Zhu, Sha, Dai, Jindong, Ni, Yuchao, Xu, Nanwei, Zhao, Fengnian, He, Ben, Zhang, Xingming, Liang, Jiayu, Sun, Guangxi, Liu, Zhenhua, Shen, Pengfei, Zeng, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061444/
https://www.ncbi.nlm.nih.gov/pubmed/37007568
http://dx.doi.org/10.21037/atm-22-4318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061444/
https://www.ncbi.nlm.nih.gov/pubmed/37007568
http://dx.doi.org/10.21037/atm-22-4318

Ejemplares similares